Citations

Clear

79 citation(s) found for "Stricker".

An examination of the usability of the Mayo Test Drive remote cognitive testing platform in older adults with and without cognitive impairment
Christianson, Teresa J., Karstens, Aimee J. , Stricker, John L. , Petersen, Ronald C. , Patel, Jay Sureshbhai , Karstens, Aimee James , Kremers, Walter K. , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M. , Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia | December 20, 2022 | Volume: 18 | Issue: S7 | Pages: No page available

10.1002/alz.061834 Get It

AbstractBackgroundMayo Test Drive (MTD): Test Development through Rapid Iteration, Validation and Expansion, is a web‐based platform for self‐administered assessment for novel (Stricker Learning Span) and open access (Symbols Test) cognitive measures with previously demonstrated validity and reliability. Our study aim was to examine the usability of MTD, defined as the extent to which MTD was used to achieve the desired study goal of completing a testing session among participants willing to engage in an all‐remote study.Methods248 Mayo Clinic Study of Aging and Mayo Alzheimer’s Disease Research Center participants were invited to participate in this ancillary, uncompensated remote pilot study via email. To examine 1) willingness to participate in a remote cognitive assessment study and 2) usability of MTD, the initiation and completion rates of MTD were examined by cognitively unimpaired (CU; n = 142) and cognitively impaired (CI; n = 106) groups (see Figure 1). These rates and other factors associated with MTD feasibility were further explored across age in CU (i.e., 50–69, 70–79, and 80+ years) and specific diagnostic groups in CI (i.e., individuals with dementia, mild cognitive impairment (MCI), and possible MCI).ResultsSession completion rate (usability) was 98% across all participants who chose to participate, and, surprisingly, completion rates did not vary by age or diagnostic groups (p = .69; see Table 1). As expected, more individuals chose to participate in the CU (77%) versus CI (52%) group (p < .001). In terms of feasibility, individuals over 80 and with CI were more likely to have some contact with the study coordinator. Use of smartphones decreased with age, with most CU individuals over 70 using a personal computer (69‐73%; Table 2).ConclusionsThough the CI group was less likely to choose to participate than the CU group, out of those that did choose to participate the rate of completion was 98%. This demonstrates high usability of MTD. Study coordinator support and a flexible testing platform is critical for facilitating participation in remote testing across the aging population, and more supports and incentives may be needed for individuals with cognitive impairment to improve participation rates.
Contributions of remote, unsupervised dyadic subjective measures to identify older adults with Mild Cognitive Impairment
Nosheny, Rachel L. , Jin, Chengshi , Knight, Krissy N, Banh, Timothy, Howell, Taylor, Truran‐Sacrey, Diana, Fockler, Juliet , Bui, Chau, Gummadi, Shilpa, Santhakumar, Jessica , Ashford, Miriam T. , Camacho, Monica R. , Flenniken, Derek , Moulder, Krista L., Li, Yan , Petersen, Ronald C. , Carrillo, Marı́a C., Mackin, R. Scott , Weiner, Michael W. , Roberson, Erik D. , Morris, John C. , Stricker, Nikki H. , Rabinovici, Gil D. , Neuhaus, John M

Mayo Clinic

Alzheimer's & Dementia | December 20, 2022 | Volume: 18 | Issue: S7 | Pages: No page available

10.1002/alz.061353 Get It

AbstractBackgroundDyadic (self and study partner) subjective reports of an individual’s recent cognitive and functional decline are an efficient approach to facilitate identification of older adults with, and at risk for, Mild Cognitive Impairment (MCI). Such methods can be easily adapted for remote administration, but few studies have investigated the ability of remotely‐collected, unsupervised dyadic subjective reports to accurately detect MCI and cognitive decline.MethodsIn 289 older adults enrolled in the Brain health Registry (BHR), with clinically‐confirmed diagnoses of Cognitively‐unimpaired (CU) or MCI, we identified the optimal combination of remote measures to accurately distinguish CU from MCI. We then externally validated our predictive model in 217 participants enrolled in a separate cohort, Validation of Online Methods to Predict Cognitive Decline (eVAL). Predictors included Cogstate Brief Battery One Card Learning (OCL) accuracy; self‐ and study partner‐reported memory concern (SMCs); performance on online adaptations of Everyday Cognition Scale (ECog, self‐ and study partner‐report versions), Geriatric Depression Scale Short Form (GDS); family history of AD, age, gender, and education. We calculated 10‐fold cross validated area under the ROC curves (cvAUC), 95% confidence intervals (CI), and the percentage of participants correctly classified (accuracy) for all models. Likelihood ratio (LR) tests were used to compare model fits.ResultsIn the BHR cohort, models including dyad‐report ECog, family history of AD, GDS, and Cogstate OCL scores distinguished CU from MCI with the highest accuracy (cvAUC = 0.90; 95% CI = 0.83, 0.92; accuracy = 85.5%). Models excluding study partner‐report ECog distinguished diagnostic groups with moderate accuracy (cvAUC = 0.83; 95% CI = 0.78, 0.85; accuracy = 75.9%) When applied to the validation cohort, the optimal training model including dyadic report performed with moderate accuracy ( Table 2 ). In the validation cohort, inclusion of study partner (but not self) report SMC, in addition to dyadic‐report ECog, improved model fit (LR test p<0.01).ConclusionsRemotely‐collected dyadic subjective measures, along with other remote measures, accurately distinguish CU from MCI. Subjective cognitive and functional decline and concerns about memory problems independently contribute to diagnostic discrimination. Results support future utilization of remote dyadic subjective measures to efficiently identify older adults with MCI for prodromal AD clinical trials, and in clinical care settings.
An examination of the usability of the Mayo Test Drive remote cognitive testing platform in older adults with and without cognitive impairment
Christianson, Teresa J., Karstens, Aimee J. , Stricker, John L. , Petersen, Ronald C. , Patel, Jay Sureshbhai , Karstens, Aimee James , Kremers, Walter K. , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M. , Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia | December 20, 2022 | Volume: 18 | Issue: S2 | Pages: No page available

10.1002/alz.063691 Get It

AbstractBackgroundMayo Test Drive (MTD): Test Development through Rapid Iteration, Validation and Expansion, is a web‐based platform for self‐administered assessment for novel (Stricker Learning Span) and open access (Symbols Test) cognitive measures with previously demonstrated validity and reliability. Our study aim was to examine the usability of MTD, defined as the extent to which MTD was used to achieve the desired study goal of completing a testing session among participants willing to engage in an all‐remote study.Methods248 Mayo Clinic Study of Aging and Mayo Alzheimer’s Disease Research Center participants were invited to participate in this ancillary, uncompensated remote pilot study via email. To examine 1) willingness to participate in a remote cognitive assessment study and 2) usability of MTD, the initiation and completion rates of MTD were examined by cognitively unimpaired (CU; n = 142) and cognitively impaired (CI; n = 106) groups (see Figure 1). These rates and other factors associated with MTD feasibility were further explored across age in CU (i.e., 50‐69, 70‐79, and 80+ years) and specific diagnostic groups in CI (i.e., individuals with dementia, mild cognitive impairment (MCI), and possible MCI).ResultsSession completion rate (usability) was 98% across all participants who chose to participate, and, surprisingly, completion rates did not vary by age or diagnostic groups (p =.69; see Table 1). As expected, more individuals chose to participate in the CU (77%) versus CI (52%) group (p < .001). In terms of feasibility, individuals over 80 and with CI were more likely to have some contact with the study coordinator. Use of smartphones decreased with age, with most CU individuals over 70 using a personal computer (69‐73%; Table 2).ConclusionsThough the CI group was less likely to choose to participate than the CU group, out of those that did choose to participate the rate of completion was 98%. This demonstrates high usability of MTD. Study coordinator support and a flexible testing platform is critical for facilitating participation in remote testing across the aging population, and more supports and incentives may be needed for individuals with cognitive impairment to improve participation rates.
Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument‐Short Form
Howell, Taylor, Gummadi, Shilpa, Bui, Chau, Santhakumar, Jessica , Knight, Kristen, Roberson, Erik D. , Marson, Daniel , Chambless, Carol, Gersteneker, Adam, Martin, Roy C. , Kennedy, Richard , Morris, John C. , Moulder, Krista L., Mayo, Connie, Carroll, Maria , Li, Yan , Petersen, Ronald C. , Nosheny, Rachel L. , Mackin, Scott, Weiner, Michael W. , Stricker, Nikki H. , Roberson, Erik , Kennedy, Richard E , Morris, John C , Zhang, Yue

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | July 24, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12331 | PMID 35898521 Get It

AbstractIntroductionTo address the need for remote assessments of cognitive decline and dementia, we developed and administered electronic versions of the Clinical Dementia Rating (CDR®) and the Financial Capacity Instrument‐Short Form (FCI‐SF) (F‐CAP®), called the eCDR and eFCI, respectively.MethodsThe CDR and FCI‐SF were adapted for remote, unsupervised, online use based on item response analysis of the standard instruments. Participants completed the eCDR and eFCI first in clinic, and then at home within 2 weeks.ResultsOf the 243 enrolled participants, 179 (73%) cognitively unimpaired (CU), 50 (21%) with mild cognitive impairment (MCI) or dementia, and 14 (6%) with an unknown diagnosis, 84% and 85% of them successfully completed the eCDR and eFCI, respectively, at home.DiscussionThese results show initial feasibility in developing and administering online instruments to remotely assess and monitor cognitive decline along the CU to MCI/very mild dementia continuum. Validation is an important next step.
Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
Alden, Eva , Twohy, Erin , Christianson, Teresa J., Kremers, Walter K. , Jack, Clifford R. , Petersen, Ronald C. , Alden, Eva C, Lundt, Emily S. , Twohy, Erin L, Stricker, Nikki H. , Jack, Clifford R , Kremers, Walter K , Machulda, Mary M. , Knopman, David S. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | July 15, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12325 | PMID 35860792 Get It

Abstract Introduction The aim of this study was to develop a conditional normative model for Rey's Auditory Verbal Learning Test (AVLT) that accounts for practice effects. Methods In our normative sample, robust conditional norms were derived from 1001 cognitively unimpaired (CU) adults ages 50 to 89 who completed the AVLT up to eight times. Linear mixed‐effects models adjusted for baseline performance, prior test exposures, time, demographics, and interaction terms. In our preliminary validation, mean performance on conditional and typical normative scores across two to four completed follow‐up tests in preclinical Alzheimer's disease participants at baseline with positive amyloid and tau positron emission ( n = 27 CU amyloid [A]+tau[T]+) was compared to biomarker negative individuals ( n = 269 CU A–T–). Results AVLT performance using typical norms did not differ across A+T+ and A–T– groups. Conditional norms z‐scores were lower in the A+T+ relative to the A–T– group for 30‐minute recall ( P = .033) and sum of trials ( P = .030). Discussion Conditional normative methods that account for practice effects show promise for identifying longitudinal cognitive decline.
Failed Performance on the Test of Memory Malingering and Misdiagnosis in Individuals with Early-Onset Dysexecutive Alzheimer’s Disease
Corriveau‐Lecavalier, Nick , Alden, Eva , Alden, Eva C, Stricker, Nikki H. , Corriveau-Lecavalier, Nick , Machulda, Mary M. , Jones, David T.

Mayo Clinic

Archives of Clinical Neuropsychology | March 16, 2022 | Volume: 37 | Issue: 6 | Pages: 1199-1207

10.1093/arclin/acac016 | PMID 35435228 Get It

Abstract Objective Individuals with early-onset dysexecutive Alzheimer’s disease (dAD) have high rates of failed performance validity testing (PVT), which can lead to symptom misinterpretation and misdiagnosis. Method The aim of this retrospective study is to evaluate rates of failure on a common PVT, the test of memory malingering (TOMM), in a sample of clinical patients with biomarker-confirmed early-onset dAD who completed neuropsychological testing. Results We identified seventeen patients with an average age of symptom onset at 52.25 years old. Nearly fifty percent of patients performed below recommended cut-offs on Trials 1 and 2 of the TOMM. Four of six patients who completed outside neuropsychological testing were misdiagnosed with alternative etiologies to explain their symptomatology, with two of these patients’ performances deemed unreliable based on the TOMM. Conclusions Low scores on the TOMM should be interpreted in light of contextual and optimally biological information and do not necessarily rule out a neurodegenerative etiology.
A novel computer adaptive word list memory test optimized for remote assessment: Psychometric properties and associations with neurodegenerative biomarkers in older women without dementia
Stricker, John L. , Karstens, Aimee J. , Geske, Jennifer R. , Fields, Julie A. , Hassenstab, Jason , Tosakulwong, Nirubol , Wiste, Heather J. , Jack, Clifford R. , Kantarci, Kejal , Stricker, Nikki H. , Jack, Clifford R , Kantarci, Kejal , Hassenstab, Jason , Geske, Jennifer , Karstens, Aimee James , Schwarz, Christopher G. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | March 9, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12299 | PMID 35280963 Get It

AbstractIntroductionThis study established the psychometric properties and preliminary validity of the Stricker Learning Span (SLS), a novel computer adaptive word list memory test designed for remote assessment and optimized for smartphone use.MethodsWomen enrolled in the Mayo Clinic Specialized Center of Research Excellence (SCORE) were recruited via e‐mail or phone to complete two remote cognitive testing sessions. Convergent validity was assessed through correlation with previously administered in‐person neuropsychological tests (n = 96, ages 55–79) and criterion validity through associations with magnetic resonance imaging measures of neurodegeneration sensitive to Alzheimer's disease (n = 47).ResultsSLS performance significantly correlated with the Auditory Verbal Learning Test and measures of neurodegeneration (temporal meta‐regions of interest and entorhinal cortical thickness, adjusting for age and education). Test–retest reliabilities across two sessions were 0.71–0.76 (two‐way mixed intraclass correlation coefficients).DiscussionThe SLS is a valid and reliable self‐administered memory test that shows promise for remote assessment of aging and neurodegenerative disorders.
Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
Shir, Dror , Graff‐Radford, Jonathan, Hofrenning, Ekaterina I. , Lesnick, Timothy G. , Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi , Campbell, Michelle R. , Stricker, Nikki H. , Jack, Clifford R , Vemuri, Prashanthi , Shir, Dror , Graff‐Radford, Jonathan , Knopman, David S. , Algeciras‐Schimnich, Alicia , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | February 28, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12291 | PMID 35252538 Get It

Abstract Introduction : Plasma glial fibrillary acidic protein (GFAP) may be associated with amyloid burden, neurodegeneration, and stroke but its specificity for Alzheimer's disease (AD) in the general population is unclear. We examined associations of plasma GFAP with amyloid and tau positron emission tomography (PET), cortical thickness, white matter hyperintensities (WMH), and cerebral microbleeds (CMBs). Methods : The study included 200 individuals from the Mayo Clinic Study of Aging who underwent amyloid and tau PET and magnetic resonance imaging and had plasma GFAP concurrently assayed; multiple linear regression and hurdle model analyses were used to investigate associations controlling for age and sex. Results : GFAP was associated with amyloid and tau PET in multivariable models. After adjusting for amyloid, the association with tau PET was no longer significant. GFAP was associated with cortical thickness, WMH, and lobar CMBs only among those who were amyloid‐positive. Discussion : This cross‐sectional analysis demonstrates the utility of GFAP as a plasma biomarker for AD‐related pathologies.
Mayo Test Drive: Reliability and construct validity of the Stricker Learning Span and Symbols Test on a self‐administered web‐based testing platform optimized for smartphone
Karstens, Aimee J. , Stricker, John L. , Fields, Julie A. , Karstens, Aimee James , Geske, Jennifer R. , Hassenstab, Jason , Mielke, Michelle M. , Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia | December 31, 2021 | Volume: 17 | Issue: S6 | Pages: No page available

10.1002/alz.057614 Get It

AbstractBackgroundMayo Test Drive (MTD): Test Development through Rapid Iteration, Validation and Expansion, is a web‐based platform for remote self‐administered assessment for novel (Stricker Learning Span; SLS) and open access (Symbols Test) cognitive measures. The SLS is a computer adaptive word‐list memory test that matches test difficulty to user performance. The SLS visually presents words for learning exposures and 4‐choice recognition to test encoding across 5 trials. Symbols is a measure of processing speed being used in many remote assessment studies and typically employs a burst design; in MTD participants complete 4 trials (12‐items each). We examine validity and reliability of the SLS and Symbols via MTD.MethodForty‐five women enrolled in an ongoing study of the Sex‐Specific Effects of Endocrine Disruption on Aging and Alzheimer’s Disease were recruited via email or phone. The Auditory Verbal Learning Test (AVLT) and Digit Symbol Coding (Coding), administered in person within the past 2 years (Mean=11 months), were used to establish construct validity. Participants (91.3% White, Mean age=66.2 years, Mean education=15.3 years) were emailed a link to complete the SLS and Symbols remotely at their convenience on their own device and emailed to repeat testing after approximately 1 week. Pearson correlations (n=45) and 2‐way mixed intraclass correlation coefficients (ICC; n=42) determined construct validity and test‐retest reliability, respectively. Significance was set at p<.05.ResultAcross all test sessions initiated, 97% were successfully completed. Most were completed at home (92.6%; vs. at work or in a public space), and device type varied (48% smartphone, 2% tablet, 50% PC). Median session completion time was 15 minutes. SLS learning scores (max span, total correct trials 1‐5) significantly correlated with AVLT 1‐5 total (r’s .37‐.39) and AVLT Trial 5 (r’s .51‐.52). SLS delay significantly correlated with AVLT delay (r=0.45) and recognition (r=0.61). Symbols time‐based scores averaged across trials were significantly correlated with Coding (r’s=‐.48‐(‐).50). Test‐retest reliabilities across 2 sessions were high for SLS (ICC’s=.80‐.88) and Symbols (ICC’s=.81‐.82).ConclusionSLS and Symbols are valid and reliable self‐administered remote tests in older females. Future work will examine effects of Alzheimer’s disease neuroimaging biomarkers and risk factors on these tests.
A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer’s Disease Based on Cogstate One Card Learning Accuracy Performance
Pudumjee, Shehroo B. , Lundt, Emily S. , Albertson, Sabrina M., Kremers, Walter K. , Petersen, Ronald C. , Stricker, Nikki H. , Kremers, Walter K , Machulda, Mary M. , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M. , Lundt, Emily S

Mayo Clinic

Journal of Alzheimer's Disease | August 6, 2021 | Volume: 83 | Issue: 2 | Pages: 861-877

10.3233/jad-210251 | PMID 34366338 Get It

Background: Longitudinal, but not cross-sectional, cognitive testing is one option proposed to define transitional cognitive decline for individuals on the Alzheimer’s disease continuum. Objective: Compare diagnostic accuracy of cross-sectional subtle objective cognitive impairment (sOBJ) and longitudinal objective decline (ΔOBJ) over 30 months for identifying 1) cognitively unimpaired participants with preclinical Alzheimer’s disease defined by elevated brain amyloid and tau (A+T+) and 2) incident mild cognitive impairment (MCI) based on Cogstate One Card Learning (OCL) accuracy performance. Methods: Mayo Clinic Study of Aging cognitively unimpaired participants aged 50 + with amyloid and tau PET scans (n = 311) comprised the biomarker-defined sample. A case-control sample of participants aged 65 + remaining cognitively unimpaired for at least 30 months included 64 who subsequently developed MCI (incident MCI cases) and 184 controls, risk-set matched by age, sex, education, and visit number. sOBJ was assessed by OCL z-scores. ΔOBJ was assessed using within subjects’ standard deviation and annualized change from linear regression or linear mixed effects (LME) models. Concordance measures Area Under the ROC Curve (AUC) or C-statistic and odds ratios (OR) from conditional logistic regression models were derived. sOBJ and ΔOBJ were modeled jointly to compare methods. Results: sOBJ and ΔOBJ-LME methods differentiated A+T+ from A-T- (AUC = 0.64, 0.69) and controls from incident MCI (C-statistic = 0.59, 0.69) better than chance; other ΔOBJ methods did not. ΔOBJ-LME improved prediction of future MCI over baseline sOBJ (p = 0.003) but not over 30-month sOBJ (p = 0.09). Conclusion: Longitudinal decline did not offer substantial benefit over cross-sectional assessment in detecting preclinical Alzheimer’s disease or incident MCI.